ArticleThe New England journal of medicine2011
Myeloma and second primary cancers.
Article in The New England journal of medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- The risk and survival of multiple myeloma as the second primary malignancy in a single Chinese center.Translational cancer research · 2024Article
- Article
- Second Primary Malignancies of the Bones and Joints: More Common than Expected in Osteosarcoma Patients.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2023Article
- Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands.Blood cancer journal · 2022Article
- Nivolumab Effective for Gastric and Lung Cancers but Not for Multiple Myeloma in a Multiple Primary Cancer Patient.Case reports in hematology · 2021Article
- Trends in cause of death among patients with multiple myeloma in Puerto Rico and the United States SEER population, 1987-2013.International journal of cancer · 2020Article
- Thalidomide-induced serious RR interval prolongation (longest interval >5.0 s) in multiple myeloma patient with rectal cancer: A case report.Open medicine (Warsaw, Poland) · 2020Article
- Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma.Leukemia · 2019Article
- [A retrospective clinical analysis of malignant tumor associated with or secondary multiple myeloma].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2018Article
- The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study.Blood advances · 2017Article
- Article
- Survival in multiple myeloma patients who develop second malignancies: a population-based cohort study.Haematologica · 2016Article
- Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries.Scientific reports · 2016Article
- Autopsy Analysis may Contribute to Establish Actual Incidence of Second Primary Malignancies in Myeloma.Rare tumors · 2015Article
- Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years.Haematologica · 2015Article
- Review
- Stomach carcinoma presenting with a synchronous liver cancer: a case report and literature review.Case reports in gastrointestinal medicine · 2014Article
- Lenalidomide inhibits lymphangiogenesis in preclinical models of mantle cell lymphoma.Cancer research · 2013Article
- Longitudinal bone marrow evaluations for myelodysplasia in patients with myeloma before and after treatment with lenalidomide.Leukemia & lymphoma · 2013Article
- Time trend of multiple myeloma and associated secondary primary malignancies in Asian patients: a Taiwan population-based study.PloS one · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.